medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2022, Number 2

<< Back Next >>

Rev Nefrol Dial Traspl 2022; 42 (2)

Evaluation of Dickkopf-3 in acute kidney injury in patients undergoing coronary angiography: A pilot atudy

Toprak Z, Bostancı GI, Çiçek YG, Aktürk IF, Toprak ID, Cebeci E, Akar E, Yılmaz M, Apaydın S

Language: English
References: 21
Page: 109-116
PDF size: 232.17 Kb.


ABSTRACT

Introduction: Urinary dickkopf-3 (DKK3), which is a kidney tubular stress marker has been suggested recently for preoperative identification of patients at risk of acute kidney injury. We aimed to assess the predictive role of urinary DKK3/creatinine (Cr) ratio in contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). Methods: This prospective observational study included patients undergoing elective PCI. The association between the ratio of precontrast urinary concentrations of DKK3/Cr and post contrast CIN was evaluated. The serum Cr, urinary DKK3 and Cr levels of the patients were measured before and after contrast media administration, and the sensitivity of urinary DKK3/Cr ratio in diagnosing CIN in the early stage was assessed by the area under receiver operating characteristic curve. Results: A total of 44 patients (33 males) undergoing PCI were enrolled and mean age of the patients was 61.5 ± 10.0 years. 22.7% of the patients developed CIN, none of them received hemodialysis during hospitalization. The mean urinary DKK3/Cr ratio was 950 ± 491 pg/mg in the CIN patients versus 386 ± 272 pg/mg in the non- CIN patients before contrast media administration (p=0.001). The mean urinary DKK3/Cr ratio was 1266 ± 738 pg/mg in the CIN patients versus 305 ± 192 pg/mg in the non- CIN patients at 12th hour after contrast media infusion (p<0.001). The roc-curve for the urinary DKK3/Cr ratio before contrast administration (AUC=0.835, p=0.001). Conclusions: Pre-contrast urinary DKK3/Cr ratio is a predictor for CIN. Urinary DKK3/Cr ratio may help in the identification of patients who are at risk of CIN.


REFERENCES

  1. McCullough PA. Contrast-induced acute kidney injury. JAm Coll Cardiol. 2008;51(15):1419-28. doi: 10.1016/j.jacc.2007.12.035.

  2. Rudnick MR, Goldfarb S. Pathogenesis of contrastinducednephropathy: experimental and clinicalobservations with an emphasis on the role of osmolality.Rev Cardiovasc Med. 2003;4(Suppl. 5):S28-33.

  3. Persson PB, Hansell P, Liss P. Pathophysiology ofcontrast medium-induced nephropathy. KidneyInt. 2005 Jul;68(1):14-22. doi: 10.1111/j.1523-1755.2005.00377.x.

  4. Haller C, Hizoh I. The cytotoxicity of iodinatedradiocontrast agents on renal cells in vitro. InvestRadiol. 2004;39(3):149-54. doi: 10.1097/01.rli.0000113776.87762.49.

  5. Kidney Disease: Improving Global Outcomes (KDIGO)Acute Kidney Injury Work Group. KDIGO clinicalpractice guideline for acute kidney injury. Kidney IntSuppl. 2012;2(1):1-138.

  6. Federico G, Meister M, Mathow D, Heine GH,Moldenhauer G, Popovic ZV, et al. Tubular Dickkopf-3promotes the development of renal atrophy and fibrosis.JCI Insight. 2016;1(1):e84916. doi: 10.1172/jci.insight.84916.

  7. Schunk SJ, Zarbock A, Meersch M, Küllmar M, KellumJA, Schmit D, et al. Association between urinarydickkopf-3, acute kidney injury, and subsequent lossof kidney function in patients undergoing cardiacsurgery: an observational cohort study. Lancet.2019;394(10197):488-96. doi: 10.1016/S0140-6736(19)30769-X.

  8. Zewinger S, Rauen T, Rudnicki M, Federico G,Wagner M, Triem S, et al. Dickkopf-3 (DKK3) in urineidentifies patients with short-term risk of eGFR loss. JAm Soc Nephrol. 2018;29(11):2722-33. doi: 10.1681/ASN.2018040405.

  9. Chertow GM, Burdick E, Honour M, Bonventre JV,Bates DW. Acute kidney injury, mortality, length of stay,and costs in hospitalized patients. J Am Soc Nephrol.2005;16(11):3365-70. doi: 10.1681/ASN.2004090740.

  10. Waybill MM, Waybill PN. Contrast media-inducednephrotoxicity: identification of patients at riskand algorithms for prevention. J Vasc Interv Radiol.2001;12(1):3-9. doi: 10.1016/s1051-0443(07)61394-3.

  11. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD,Genge M, Withers J, et al. Contrast material-inducedrenal failure in patients with diabetes mellitus, renalinsufficiency, or both. A prospective controlled study.N Engl J Med. 1989;320(3):143-9. doi: 10.1056/NEJM198901193200303.

  12. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH,Best PJ, et al. Incidence and prognostic importanceof acute renal failure after percutaneous coronaryintervention. Circulation. 2002;105(19):2259-64. doi:10.1161/01.cir.0000016043.87291.33.

  13. Rudnick MR, Davidson C, Laskey W, Stafford JL,Sherwin PF; VALOR Trial Investigators. Nephrotoxicityof iodixanol versus ioversol in patients with chronickidney disease: the Visipaque Angiography/Interventionswith Laboratory Outcomes in Renal Insufficiency(VALOR) Trial. Am Heart J. 2008;156(4):776-82. doi:10.1016/j.ahj.2008.05.023.

  14. Aspelin P, Aubry P, Fransson SG, Strasser R, WillenbrockR, Berg KJ; Nephrotoxicity in High-Risk Patients Studyof Iso-Osmolar and Low-Osmolar Non-Ionic ContrastMedia Study Investigators. Nephrotoxic effects in highriskpatients undergoing angiography. N Engl J Med.2003;348(6):491-9. doi: 10.1056/NEJMoa021833.

  15. Schwab SJ, Hlatky MA, Pieper KS, DavidsonCJ, Morris KG, Skelton TN, et al. Contrastnephrotoxicity: a randomized controlled trial of anonionic and an ionic radiographic contrast agent.N Engl J Med. 1989;320(3):149-53. doi: 10.1056/NEJM198901193200304.

  16. Rich MW, Crecelius CA. Incidence, risk factors,and clinical course of acute renal insufficiency aftercardiac catheterization in patients 70 years of ageor older. A prospective study. Arch Intern Med.1990;150(6):1237-42.

  17. Sánchez Álamo B, Corona CMC, García Ińigo FJ,Domínguez Torres P, Shabaka Fernández A, Ocańa J,et al. Urinary Dickkopf-3 (Dkk3) as a predictive factorfor renal survival in established diabetic nephropathy.Nephrol Dial Transplant. 2019;34(Suppl. 1):207-8. doi:10.1093/ndt/gfz106.FP489.

  18. Seibert FS, Heringhaus A, Pagonas N, Rohn B, BauerF, Trappe HJ, et al. Dickkopf-3 in the prediction ofcontrast media induced acute kidney injury. J Nephrol.2021;34(3):821-8. doi: 10.1007/s40620-020-00910-1.

  19. Piek A, Suthahar N, Voors AA, de Boer RA, SilljéHHW. A combined bioinformatics, experimental andclinical approach to identify novel cardiac-specific heartfailure biomarkers: is Dickkopf-3 (DKK3) a possiblecandidate? Eur J Heart Fail. 2020;22(11):2065-74. doi:10.1002/ejhf.1988.

  20. Faucon AL, Bobrie G, Clément O. Nephrotoxicityof iodinated contrast media: From pathophysiology toprevention strategies. Eur J Radiol. 2019;116:231-41.doi: 10.1016/j.ejrad.2019.03.008.

  21. van der Molen AJ, Reimer P, Dekkers IA, Bongartz G,Bellin MF, Bertolotto M, et al. Post-contrast acute kidneyinjury - Part 1: Definition, clinical features, incidence, roleof contrast medium and risk factors : Recommendationsfor updated ESUR Contrast Medium Safety Committeeguidelines. Eur Radiol. 2018;28(7):2845-55. doi:10.1007/s00330-017-5246-5.




2020     |     www.medigraphic.com